Health
Daiichi Sankyo says it has begun producing AstraZeneca’s COVID-19 vaccine in Japan – TheChronicleHerald.ca
TOKYO (Reuters) – Daiichi Sankyo Co said on Friday it had begun the production of AstraZeneca Plc’s COVID-19 vaccine in Japan. The drugmaker said in a release it…
TOKYO (Reuters) – Daiichi Sankyo Co said on Friday it had begun the production of AstraZeneca Plc’s COVID-19 vaccine in Japan.
The drugmaker said in a release it will prepare the vaccine in Japan, including vial filling and packaging, using the bulk solution provided by AstraZeneca.
The Japanese government has already arranged to buy 120 million doses of AstraZeneca’s vaccine, enough for 60 million people. Most of the doses will be made in Japan by Daiichi Sankyo, JCR Pharma and other local partners.
…
-
Business22 hours agoCould a small investor today match the historic returns of Warren Buffett?
-
General15 hours agoMan charged with murder after alleged assault victim dies in Hervey Bay
-
Noosa News14 hours agoPublic health alert for nitazenes issued after person dies in Queensland
-
General16 hours agoGrieving Bunbury family outraged over plan to remove roadside memorial